Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure characterized by impaired cardiac filling. In a recent study, his group and ...

In a study published in Neuron, a research team at the Department of Neurology at Massachusetts General Hospital, aimed to ...

Ignorance of active railroad crossings is just one of many issues that Tesla's self-driving tech has seemingly not accounted ...

And the race is centered on one idea: transformer-based architecture with large language models are the key to winning the AI ...

A functional medicine expert explains how looking at the root cause, not just symptoms, can help where conventional medicine ...

A new study has identified a mutation in the TREM2 gene that disrupts the brain’s ability to clear toxic amyloid plaques, increasing Alzheimer’s disease risk.

The new program is validated in a set of clinical pedigrees demonstrating its practical accuracy and relevance to the field. Collectively, the data are compelling and support the major conclusions of ...

An AI chatbot developed by TikTok's parent company, ByteDance, is now more popular than DeepSeek. The feat proves that ...

Dominika Pilat, PhD, and Ana Griciuc, PhD, of the Department of Neurology at Massachusetts General Hospital are the lead and senior authors of a paper published in Neuron, "The Gain-of-Function ...

RFK Jr.’s moves to limit animal testing in drug trials could pull animal rights voters into the Republican camp, experts say.

A new study published in Experimental Eye Research reported that the preclinical results achieved with SPG302 (Spinogenix, ...

MotorTrend’s experts tested everything from hybrids to sports cars — and one model earned the top automotive honor for 2026.